Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rafla

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Archives of Otolaryngology--Head & Neck Surgery|February 1, 1991
Effectiveness of radiotherapy with radical neck dissection in cancers of the head and neckR A Khafif, S Rafla, P Tepper, et al.
Radiology|August 1, 1988
Changes in T-cell subsets after radiation therapyS J Yang, S Rafla, E Youssef, et al.
Journal of Chronic Diseases|January 1, 1987
A brief POMS measure of distress for cancer patientsD F Cella, P B Jacobsen, E J Orav, et al.
Cancer Treatment Reports|November 1, 1983
Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B studyP C Amrein, M Coleman, F Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB StudyM R Cooper, O R McIntyre, K J Propert, et al.
Cancer Clinical Trials|January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B studyV Vinciguerra, M Coleman, T F Pajak, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Blood|July 1, 1984
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group BA J Gottlieb, V Weinberg, R R Ellison, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Archives of Otolaryngology--Head & Neck Surgery|February 1, 1991
Effectiveness of radiotherapy with radical neck dissection in cancers of the head and neckR A Khafif, S Rafla, P Tepper, et al.
Radiology|August 1, 1988
Changes in T-cell subsets after radiation therapyS J Yang, S Rafla, E Youssef, et al.
Journal of Chronic Diseases|January 1, 1987
A brief POMS measure of distress for cancer patientsD F Cella, P B Jacobsen, E J Orav, et al.
Cancer Treatment Reports|November 1, 1983
Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B studyP C Amrein, M Coleman, F Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB StudyM R Cooper, O R McIntyre, K J Propert, et al.
Cancer Clinical Trials|January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B studyV Vinciguerra, M Coleman, T F Pajak, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Blood|July 1, 1984
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group BA J Gottlieb, V Weinberg, R R Ellison, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Pageof 4